Although guidelines for surgical decision-making in patients with acute subdural hematomas (ASDHs) are widely available, the evidence supporting these guidelines is weak, and management of these patients must often be individualized. Smaller ASDHs in patients in good neurologic condition usually can be successfully managed without surgery. Large ASDHs with minimal mass effect in patients with minimal symptoms also may be considered for nonoperative management. The literature is divided about the effects of anticoagulant and antiplatelet medications on rapid growth of ASDHs and on their likelihood of progression to large chronic subdural hematomas, but it is reasonable to reverse the effects of these medications promptly. Close clinical and radiologic follow-up is needed in these patients, both acutely to detect rapid expansion of an ASDH, and subacutely to detect formation of a large subacute or chronic subdural hematoma
